title: Value of gated SPECT in the analysis of regional wall motion of the interventricular septum after coronary artery bypass grafting.
abstract: OBJECTIVE
  The aim of this study was the evaluation of septal wall motion, perfusion and wall thickening after CABG in two groups of consecutive patients, one with grafted left anterior coronary artery and no history of myocardial infarction, and the other with previous anteroseptal myocardial infarction and impaired septal motion before surgery. The issue addressed was the ability of gated SPECT to differentiate between true paradoxical septal motion, characterised by paradoxical wall motion, depressed ejection fraction (EF), poor viability and compromised wall thickening, and pseudo-paradoxical motion, characterised by abnormal wall motion and regional EF but preserved perfusion and wall thickening.
  
  
  METHODS
  One hundred and thirty-two patients with previous anterior myocardial infarction, 82 patients with left anterior descending coronary disease and no history of myocardial infarction and 27 normal subjects underwent rest gated SPECT after 99mTc-sestamibi injection, according to the standard QGS protocol. Quantitative regional EF, regional perfusion, regional wall motion and regional wall thickening were determined using a 20-segment model.
  
  
  RESULTS
  Despite the presence of similar regional wall motion impairment in patients with and patients without septal infarction, in terms of regional EF (2.5%+/-3% vs 1.9%+/-4.9% p=NS) and inward septal motion (3+/-4.9 mm vs 2.3+/-6.1 mm p=NS), significant differences were observed in both perfusion (74.7%+/-6.2% vs 63.3%+/-13%, p>0.0001) and regional wall thickening (17.2%+/-7.4% vs 12.6%+/-7.2%, p>0.0001).
  
  
  CONCLUSIONS
  Gated SPECT with perfusion tracers can reliably differentiate pseudo-paradoxical from true paradoxical septal motion in patients with previous CABG, and it may be the method of choice for evaluating left ventricular performance in this patient population.
authors.affiliation: Department of Nuclear Medicine, Spedali Civili di Brescia, Brescia, Italy. giubbini@spedalicivili.brescia.it
authors.forename: Raffaele
authors.initials: R
authors.lastname: Giubbini
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Rossini
authors.forename: Francesco
authors.initials: F
authors.lastname: Bertagna
authors.forename: Giovanni
authors.initials: G
authors.lastname: Bosio
authors.forename: Barbara
authors.initials: B
authors.lastname: Paghera
authors.forename: Claudio
authors.initials: C
authors.lastname: Pizzocaro
authors.forename: Silvana
authors.initials: S
authors.lastname: Canclini
authors.forename: Arturo
authors.initials: A
authors.lastname: Terzi
authors.forename: Guido
authors.initials: G
authors.lastname: Germano
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000601:surgery*; D005260:Female; D015637:Gated Blood-Pool Imaging / Q000379:methods*; D006346:Heart Septum / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009068:Movement; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000209:etiology / Q000601:surgery*; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000209:etiology
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi